Fungal Keratitis: Diagnosis, Management, and Recent Advances

References

• Ong HS, Corbett MC. Corneal infections in the 21st century. Postgrad Med J. 2015;91(1080):565–571. doi:10.1136/postgradmedj-2015-133323
   PubMed Web of Science ®Google Scholar
• Khalili MR, Jahadi HR, Karimi M, Yasemi M. Corneal collagen cross-linking for treatment of bacterial and herpetic keratitis. J Clin Diagn Res. 2017;11(7):Nc12–nc6. doi:10.7860/JCDR/2017/24863.10253
   PubMedGoogle Scholar
• Garg P, Rao GN. Corneal ulcer: diagnosis and management. Community Eye Health. 1999;12(30):21–23.
   PubMedGoogle Scholar
• Maharana PK, Sharma N, Nagpal R, Jhanji V, Das S, Vajpayee RB. Recent advances in diagnosis and management of mycotic keratitis. Indian J Ophthalmol. 2016;64(5):346–357. doi:10.4103/0301-4738.185592
   PubMed Web of Science ®Google Scholar
• Brown L, Leck AK, Gichangi M, Burton MJ, Denning DW. The global incidence and diagnosis of fungal keratitis. Lancet Infect Dis. 2021;21(3):e49–57. doi:10.1016/S1473-3099(20)30448-5
   PubMed Web of Science ®Google Scholar
• Liesegang TJ, Forster RK. Spectrum of microbial keratitis in South Florida. Am J Ophthalmol. 1980;90(1):38–47. doi:10.1016/S0002-9394(14)75075-5
   PubMed Web of Science ®Google Scholar
• Armstrong RA. The microbiology of the eye. Ophthalmic Physiol Opt. 2000;20(6):429–441. doi:10.1111/j.1475-1313.2000.tb01121.x
   PubMed Web of Science ®Google Scholar
• Colby K, Dana R. Foundations of Corneal Disease: Past, Present and Future. New York: Springer Nature; 2019.
   Google Scholar
• Robin JB, Nielson S, Trousdale MD. Fluorescein-conjugated lectin identification of a case of human keratomycosis. Am J Ophthalmol. 1986;102(6):797–798. doi:10.1016/0002-9394(86)90413-7
   PubMed Web of Science ®Google Scholar
• Coster D, Lightman S. Cornea, Fundamentals of Clinical Ophthalmology Series. London: BMS Books; 2002.
   Google Scholar
• Beebe DC. Maintaining transparency: a review of the developmental physiology and pathophysiology of two avascular tissues. Semin Cell Dev Biol. 2008;19(2):125–133. doi:10.1016/j.semcdb.2007.08.014
   PubMed Web of Science ®Google Scholar
• Dandona L, Ragu K, Janarthanan M, Naduvilath TJ, Shenoy R, Rao GN. Indications for penetrating keratoplasty in India. Indian J Ophthalmol. 1997;45(3):163–168.
   PubMedGoogle Scholar
• McDonnell PJ, Nobe J, Gauderman WJ, Lee P, Aiello A, Trousdale M. Community care of corneal ulcers. Am J Ophthalmol. 1992;114(5):531–538. doi:10.1016/S0002-9394(14)74479-4
   PubMed Web of Science ®Google Scholar
• Sadik N, Elzeiny SM, Ali YE, Sobeih D. Fungal keratitis in the Egyptian delta: epidemiology, risk factors, and microbiological diagnosis. Ophthalmic Epidemiol. 2022;29(2):198–205. doi:10.1080/09286586.2021.1914667
   PubMed Web of Science ®Google Scholar
• Ansari Z, Miller D, Galor A. Current thoughts in fungal keratitis: diagnosis and treatment. Curr Fungal Infect Rep. 2013;7(3):209–218. doi:10.1007/s12281-013-0150-1
   PubMedGoogle Scholar
• Xie L, Dong X, Shi W. Treatment of fungal keratitis by penetrating keratoplasty. Br J Ophthalmol. 2001;85(9):1070–1074. doi:10.1136/bjo.85.9.1070
   PubMed Web of Science ®Google Scholar
• Thomas PA, Leck AK, Myatt M. Characteristic clinical features as an aid to the diagnosis of suppurative keratitis caused by filamentous fungi. Br J Ophthalmol. 2005;89(12):1554–1558. doi:10.1136/bjo.2005.076315
   PubMed Web of Science ®Google Scholar
• Kalkanci A. Microbiological Diagnosis of Fungal Keratitis. In: Kalkanci A, editor. Mycotic Keratitis. Florida, United States: CRC Press; 2019:45–55.
   Google Scholar
• Rai M, Occhiutto ML. Mycotic Keratitis. Florida, United States: CRC Press; 2019.
   Google Scholar
• Gunasekaran R, Chandrasekaran A, Rajarathinam K, et al. Rapid point-of-care identification of aspergillus species in microbial keratitis. JAMA Ophthalmol. 2023;141(10):966–973. doi:10.1001/jamaophthalmol.2023.4214
   PubMedGoogle Scholar
• Prasher P, Singh B, Singh K. Novel use of trypan blue dye to stain fungus in corneal scrapings in eye clinics. Cornea. 2020;39(11):e26. doi:10.1097/ICO.0000000000002446
   PubMed Web of Science ®Google Scholar
• Garg P, Gopinathan U, Choudhary K, Rao GN. Keratomycosis: clinical and microbiologic experience with dematiaceous fungi. Ophthalmology. 2000;107(3):574–580. doi:10.1016/S0161-6420(99)00079-2
   PubMed Web of Science ®Google Scholar
• Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol. 2004;15(4):321–327. doi:10.1097/00055735-200408000-00008
   PubMedGoogle Scholar
• Thomas PA, Kaliamurthy J. Mycotic keratitis: epidemiology, diagnosis and management. Clin Microbiol Infect. 2013;19(3):210–220. doi:10.1111/1469-0691.12126
   PubMed Web of Science ®Google Scholar
• Bharathi MJ, Ramakrishnan R, Vasu S, Meenakshi R, Palaniappan R. Epidemiological characteristics and laboratory diagnosis of fungal keratitis. A three-year study. Indian J Ophthalmol. 2003;51(4):315–321.
   PubMedGoogle Scholar
• Ortega-Rosales A, Quizhpe-Ocampo Y, Montalvo-Flores M, Burneo-Rosales C, Romero-Ulloa G. A case of fungal keratitis due to Fusarium solani after an indigenous healing practice. IDCases. 2019;18:e00618.
   PubMed Web of Science ®Google Scholar
• Robaei D, Chan UT, Khoo P, et al. Corneal biopsy for diagnosis of recalcitrant microbial keratitis. Graefes Arch Clin Exp Ophthalmol. 2018;256(8):1527–1533. doi:10.1007/s00417-018-3981-1
   PubMed Web of Science ®Google Scholar
• Mahmoudi S, Masoomi A, Ahmadikia K, et al. Fungal keratitis: an overview of clinical and laboratory aspects. Mycoses. 2018;61(12):916–930. doi:10.1111/myc.12822
   PubMed Web of Science ®Google Scholar
• Kumar RL, Cruzat A, Hamrah P. Current state of in vivo confocal microscopy in management of microbial keratitis. Semin Ophthalmol. 2010;25(5–6):166–170. doi:10.3109/08820538.2010.518516
   PubMed Web of Science ®Google Scholar
• Brasnu E, Bourcier T, Dupas B, et al. In vivo confocal microscopy in fungal keratitis. Br J Ophthalmol. 2007;91(5):588–591. doi:10.1136/bjo.2006.107243
   PubMed Web of Science ®Google Scholar
• Chidambaram JD, Prajna NV, Larke N, et al. In vivo confocal microscopy appearance of Fusarium and Aspergillus species in fungal keratitis. Br J Ophthalmol. 2017;101(8):1119. doi:10.1136/bjophthalmol-2016-309656
   PubMed Web of Science ®Google Scholar
• Ferrer C, Alió JL. Evaluation of molecular diagnosis in fungal keratitis. Ten years of experience. J Ophthalmic Inflamm Infect. 2011;1(1):15–22. doi:10.1007/s12348-011-0019-9
   PubMedGoogle Scholar
• Tahvildari M, Singh RB, Saeed HN. Application of artificial intelligence in the diagnosis and management of corneal diseases. Semin Ophthalmol. 2021;36(8):641–648. doi:10.1080/08820538.2021.1893763
   PubMed Web of Science ®Google Scholar
• Saini JS, Jain AK, Kumar S, Vikal S, Pankaj S, Singh S. Neural network approach to classify infective keratitis. Curr Eye Res. 2003;27(2):111–116. doi:10.1076/ceyr.27.2.111.15949
   PubMed Web of Science ®Google Scholar
• Soleimani M, Cheraqpour K, Sadeghi R, Pezeshgi S, Koganti R, Djalilian AR. Artificial intelligence and infectious keratitis: where are we now? Life. 2023;13(11):2117. doi:10.3390/life13112117
   PubMedGoogle Scholar
• Dahlgren MA, Lingappan A, Wilhelmus KR. The clinical diagnosis of microbial keratitis. Am J Ophthalmol. 2007;143(6):940–944. doi:10.1016/j.ajo.2007.02.030
   PubMed Web of Science ®Google Scholar
• Dalmon C, Porco TC, Lietman TM, et al. The clinical differentiation of bacterial and fungal keratitis: a photographic survey. Invest Ophthalmol Vis Sci. 2012;53(4):1787–1791. doi:10.1167/iovs.11-8478
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Agrawal D, Gomase SN. Clinical differentiation of Pythium keratitis from fungal keratitis and development of a scoring system. Indian J Ophthalmol. 2022;70(10):3515. doi:10.4103/ijo.IJO_870_22
   PubMed Web of Science ®Google Scholar
• Sharma N, Sahay P, Maharana PK, et al. Management algorithm for fungal keratitis: the TST (topical, systemic, and targeted therapy) protocol. Cornea. 2019;38(2):141–145. doi:10.1097/ICO.0000000000001781
   PubMed Web of Science ®Google Scholar
• Qiu S, Zhao GQ, Lin J, et al. Natamycin in the treatment of fungal keratitis: a systematic review and Meta-analysis. Int J Ophthalmol. 2015;8(3):597–602. doi:10.3980/j.issn.2222-3959.2015.03.29
   PubMed Web of Science ®Google Scholar
• FlorCruz NV, Peczon IV, Evans JR. Medical interventions for fungal keratitis. Cochrane Database Syst Rev. 2012;2012(2):Cd004241.
   Google Scholar
• Garcia-Valenzuela E, Song CD. Intracorneal injection of amphotericin B for recurrent fungal keratitis and endophthalmitis. Arch Ophthalmol. 2005;123(12):1721–1723. doi:10.1001/archopht.123.12.1721
   PubMedGoogle Scholar
• Yildiz EH, Abdalla YF, Elsahn AF, et al. Update on fungal keratitis from 1999 to 2008. Cornea. 2010;29(12):1406–1411. doi:10.1097/ICO.0b013e3181da571b
   PubMed Web of Science ®Google Scholar
• Arora R, Gupta D, Goyal J, Kaur R. Voriconazole versus natamycin as primary treatment in fungal corneal ulcers. Clin Exp Ophthalmol. 2011;39(5):434–440. doi:10.1111/j.1442-9071.2010.02473.x
   PubMed Web of Science ®Google Scholar
• Prajna NV, John RK, Nirmalan PK, Lalitha P, Srinivasan M. A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis. Br J Ophthalmol. 2003;87(10):1235–1237. doi:10.1136/bjo.87.10.1235
   PubMed Web of Science ®Google Scholar
• Rao SK, Madhavan HN, Rao G, Padmanabhan P. Fluconazole in filamentous fungal keratitis. Cornea. 1997;16(6):700. doi:10.1097/00003226-199711000-00019
   PubMed Web of Science ®Google Scholar
• Mselle J. Use of topical clotrimazole in human keratomycosis. Ophthalmologica. 2001;215(5):357–360. doi:10.1159/000050885
   PubMed Web of Science ®Google Scholar
• Torres HA, Hachem RY, Chemaly RF, Kontoyiannis DP, Raad II. Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect Dis. 2005;5:775–785. doi:10.1016/S1473-3099(05)70297-8
   PubMed Web of Science ®Google Scholar
• Tu EY, McCartney DL, Beatty RF, Springer KL, Levy J, Edward D. Successful treatment of resistant ocular fusariosis with posaconazole (SCH-56592. Am J Ophthalmol. 2007;143:222–227. doi:10.1016/j.ajo.2006.10.048
   PubMed Web of Science ®Google Scholar
• Altun A, Kurna SA, Sengor T, et al. Effectiveness of posaconazole in recalcitrant fungal keratitis resistant to conventional antifungal drugs. Case Rep Ophthalmol Med. 2014;2014:701653. doi:10.1155/2014/701653
   PubMedGoogle Scholar
• Neoh CF, Daniell M, Chen SC, Stewart K, Kong DC. Clinical utility of caspofungin eye drops in fungal keratitis. Int J Antimicrob Agents. 2014;44(2):96–104. doi:10.1016/j.ijantimicag.2014.04.008
   PubMed Web of Science ®Google Scholar
• Patil A, Majumdar S. Echinocandins in ocular therapeutics. J Ocul Pharmacol Ther. 2017;33(5):340–352. doi:10.1089/jop.2016.0186
   PubMed Web of Science ®Google Scholar
• Prajna NV, Krishnan T, Mascarenhas J, et al. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmol. 2013;131(4):422–429. doi:10.1001/jamaophthalmol.2013.1497
   PubMed Web of Science ®Google Scholar
• Mascarenhas M, Chaudhari P, Lewis SA. Natamycin ocular delivery: challenges and advancements in ocular therapeutics. Advan Therapy. 2023;8:1–28.
   Google Scholar
• Stern GA, Okumoto M, Smolin G. Combined amphotericin B and rifampin treatment of experimental Candida albicans keratitis. Arch Ophthalmol. 1979;97(4):721–722. doi:10.1001/archopht.1979.01020010373020
   PubMedGoogle Scholar
• Beggs WH. Mechanisms of synergistic interactions between amphotericin B and flucytosine. J Antimicrob Chemother. 1986;17(4):402–404. doi:10.1093/jac/17.4.402
   PubMed Web of Science ®Google Scholar
• Sha XY, Shi Q, Liu L, Zhong JX. Update on the management of fungal keratitis. Intl Ophthalmol. 2021;41(9):3249–3256. doi:10.1007/s10792-021-01873-3
   PubMed Web of Science ®Google Scholar
• Shapiro BL, Lalitha P, Loh AR, et al. Susceptibility testing and clinical outcome in fungal keratitis. Br J Ophthalmol. 2010;94(3):384–385. doi:10.1136/bjo.2009.158675
   PubMed Web of Science ®Google Scholar
• Shi W, Li S, Liu M, Jin H, Xie L. Antifungal chemotherapy for fungal keratitis guided by in vivo confocal microscopy. Graefes Arch Clin Exp Ophthalmol. 2008;246(4):581–586. doi:10.1007/s00417-007-0719-x
   PubMed Web of Science ®Google Scholar
• Tuli SS. Fungal keratitis. Clin Ophthalmol. 2011;5:275–279. doi:10.2147/OPTH.S10819
   PubMedGoogle Scholar
• Prajna NV, Krishnan T, Rajaraman R, et al. Effect of oral voriconazole on fungal keratitis in the mycotic ulcer treatment trial II (MUTT II): a randomized clinical trial. JAMA Ophthalmol. 2016;134(12):1365–1372. doi:10.1001/jamaophthalmol.2016.4096
   PubMed Web of Science ®Google Scholar
• Cai Y, Song S, Chen Y, Xu X, Zou W. Oral voriconazole monotherapy for fungal keratitis: efficacy, safety, and factors associated with outcomes. Front Med. 2023;10:1174264. doi:10.3389/fmed.2023.1174264
   Web of Science ®Google Scholar
• Sharma N, Singhal D, Maharana PK, et al. Comparison of oral voriconazole versus oral ketoconazole as an adjunct to topical natamycin in severe fungal keratitis: a randomized controlled trial. Cornea. 2017;36(12):1521–1527. doi:10.1097/ICO.0000000000001365
   PubMed Web of Science ®Google Scholar
• Sharma N, Sachdev R, Jhanji V, Titiyal JS, Vajpayee RB. Therapeutic keratoplasty for microbial keratitis. Curr Opin Ophthalmol. 2010;21(4):293–300. doi:10.1097/ICU.0b013e32833a8e23
   PubMed Web of Science ®Google Scholar
• Ang M, Mehta JS, Sng CC, Htoon HM, Tan DT. Indications, outcomes, and risk factors for failure in tectonic keratoplasty. Ophthalmology. 2012;119(7):1311–1319. doi:10.1016/j.ophtha.2012.01.021
   PubMed Web of Science ®Google Scholar
• Benson MD, Kurji K, Tseng C, Bao B, Mah D. Analysis of penetrating keratoplasty in Northern Alberta, Canada, from 2000 to 2015. Can J Ophthalmol. 2018;53(6):568–573. doi:10.1016/j.jcjo.2018.01.024
   PubMed Web of Science ®Google Scholar
• Shi W, Wang T, Xie L, et al. Risk factors, clinical features, and outcomes of recurrent fungal keratitis after corneal transplantation. Ophthalmology. 2010;117(5):890–896. doi:10.1016/j.ophtha.2009.10.004
   PubMed Web of Science ®Google Scholar
• Gao H, Song P, Echegaray JJ, et al. Big bubble deep anterior lamellar keratoplasty for management of deep fungal keratitis. J Ophthalmol. 2014;2014:209759. doi:10.1155/2014/209759
   PubMed Web of Science ®Google Scholar
• Sabatino F, Sarnicola E, Sarnicola C, Tosi GM, Perri P, Sarnicola V. Early deep anterior lamellar keratoplasty for fungal keratitis poorly responsive to medical treatment. Eye (Lond). 2017;31(12):1639–1646. doi:10.1038/eye.2017.228
   PubMed Web of Science ®Google Scholar
• Cristol SM, Alfonso EC, Guildford JH, Roussel TJ, Culbertson WW. Results of large penetrating keratoplasty in microbial keratitis. Cornea. 1996;15(6):571–576. doi:10.1097/00003226-199611000-00006
   PubMed Web of Science ®Google Scholar
• Killingsworth DW, Stern GA, Driebe WT, Knapp A, Dragon DM. Results of therapeutic penetrating keratoplasty. Ophthalmology. 1993;100(4):534–541. doi:10.1016/S0161-6420(13)31631-5
   PubMed Web of Science ®Google Scholar
• Wang T, Li S, Gao H, Shi W. Therapeutic dilemma in fungal keratitis: administration of steroids for immune rejection early after keratoplasty. Graefes Arch Clin Exp Ophthalmol. 2016;254(8):1585–1589. doi:10.1007/s00417-016-3412-0
   PubMed Web of Science ®Google Scholar
• Gregory M, Macdonald E, Lockington D, Ramaesh K. Recurrent fungal keratitis following penetrating keratoplasty: an unusual source of infection. Arch Ophthalmol. 2010;128(11):1490–1491. doi:10.1001/archophthalmol.2010.264
   PubMedGoogle Scholar
• Prakash G, Sharma N, Goel M, Titiyal JS, Vajpayee RB. Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis. Am J Ophthalmol. 2008;146(1):56–59. doi:10.1016/j.ajo.2008.02.023
   PubMed Web of Science ®Google Scholar
• Sharma N, Agarwal P, Sinha R, Titiyal JS, Velpandian T, Vajpayee RB. Evaluation of intrastromal voriconazole injection in recalcitrant deep fungal keratitis: case series. Br J Ophthalmol. 2011;95(12):1735–1737. doi:10.1136/bjo.2010.192815
   PubMed Web of Science ®Google Scholar
• Sharma N, Chacko J, Velpandian T, et al. Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis. Ophthalmology. 2013;120(4):677–681. doi:10.1016/j.ophtha.2012.09.023
   PubMed Web of Science ®Google Scholar
• Solaiman K, Alkawas A, Ibrahim B, Mahdy M, Shalaby M. Topical voriconazole drops with and without intrastromal voriconazole injection for treatment of deep or resistant fungal keratitis. J Clin Exp Ophthalmol. 2015;6(469):1000469. doi:10.4172/2155-9570.1000469
   Google Scholar
• Killani S, Atti S, Gupta A, et al. Intracameral and intracorneal voriconazole in deep keratomycosis with endothelial plaque. J Evol Med Dent Sci. 2015;4:16476–16480. doi:10.14260/jemds/2015/2446
   Google Scholar
• Kalaiselvi G, Narayana S, Krishnan T, Sengupta S. Intrastromal voriconazole for deep recalcitrant fungal keratitis: a case series. Br J Ophthalmol. 2015;99(2):195–198. doi:10.1136/bjophthalmol-2014-305412
   PubMed Web of Science ®Google Scholar
• Hu J, Zhang J, Li Y, et al. A combination of intrastromal and intracameral injections of amphotericin B in the treatment of severe fungal keratitis. J Ophthalmol. 2016;2016:3436415. doi:10.1155/2016/3436415
   PubMed Web of Science ®Google Scholar
• Nada WM, Al Aswad MA, El-Haig WM. Combined intrastromal injection of amphotericin B and topical fluconazole in the treatment of resistant cases of keratomycosis: a retrospective study. Clin Ophthalmol. 2017;11:871–874. doi:10.2147/OPTH.S135112
   PubMed Web of Science ®Google Scholar
• Narayana S, Krishnan T, Ramakrishnan S, et al. Mycotic antimicrobial localized injection: a randomized clinical trial evaluating intrastromal injection of voriconazole. Ophthalmology. 2019;126(8):1084–1089. doi:10.1016/j.ophtha.2019.03.020
   PubMed Web of Science ®Google Scholar
• Rathi A, Chauhan RS, Singh N. To compare therapeutic efficacy of topical voriconazole eye drops alone versus topical voriconazole eye drops combined with intrastromal injection of voriconazole in recalcitrant deep fungal keratitis. Saudi J Med Pharma Sci. 2019;5(2):137–146.
   Google Scholar
• Konar P, Joshi S, Mandhare SJ, Thakur R, Deshpande M, Dayal A. Intrastromal voriconazole: an adjuvant approach for recalcitrant mycotic keratitis. Indian J Ophthalmol. 2020;68(1):35–38. doi:10.4103/ijo.IJO_378_19
   PubMed Web of Science ®Google Scholar
• Aydin B, Cubuk MO, Ucgul A, et al. Combined intrastromal voriconazole and amphotericin B treatment for persistent fungal keratitis. Eye Contact Lens. 2020;46(5):269–273. doi:10.1097/ICL.0000000000000723
   PubMed Web of Science ®Google Scholar
• Li C, Pang K, Du L, Wu X. Efficacy of voriconazole corneal intrastromal injection for the treatment of fungal keratitis. J Ophthalmol. 2021;2021:5597003. doi:10.1155/2021/5597003
   PubMed Web of Science ®Google Scholar
• Saluja G, Sharma N, Agarwal R, et al. Comparison of safety and efficacy of intrastromal injections of voriconazole, amphotericin b and natamycin in cases of recalcitrant fungal keratitis: a randomized controlled trial. Clin Ophthalmol. 2021;15:2437–2446. doi:10.2147/OPTH.S301878
   PubMed Web of Science ®Google Scholar
• Wannapanich T, Anutarapongpan O. Treatment outcomes of intrastromal voriconazole injection for fungal keratitis. Int J Biomed Res. 2022;13:6.
   Google Scholar
• Bhirud A, Mishra A, Agrawal M, Sharma J. Intrastromal voriconazole as successful adjunctive approach for recalcitrant deep fungal keratitis. Roman J Ophthalmol. 2023;67(1):7. doi:10.22336/rjo.2023.3
   PubMedGoogle Scholar
• Goudar S, Amulya P, Mridula AK, Seethalakshmi DK. Prospective interventional study of intrastromal voriconazole injection in nonhealing fungal keratitis. MRIMS J Health Sci. 2023;2023:1.
   Google Scholar
• Kuriakose T, Kothari M, Paul P, Jacob P, Thomas R. Intracameral amphotericin B injection in the management of deep keratomycosis. Cornea. 2002;21(7):653–656. doi:10.1097/00003226-200210000-00004
   PubMed Web of Science ®Google Scholar
• Yoon KC, Jeong IY, Im SK, Chae HJ, Yang SY. Therapeutic effect of intracameral amphotericin B injection in the treatment of fungal keratitis. Cornea. 2007;26(7):814–818. doi:10.1097/ICO.0b013e31806c791e
   PubMed Web of Science ®Google Scholar
• Shen YC, Wang CY, Tsai HY, Lee HN. Intracameral voriconazole injection in the treatment of fungal endophthalmitis resulting from keratitis. Am J Ophthalmol. 2010;149(6):916–921. doi:10.1016/j.ajo.2010.01.024
   PubMed Web of Science ®Google Scholar
• Shao Y, Yu Y, Pei CG, et al. Therapeutic efficacy of intracameral amphotericin B injection for 60 patients with keratomycosis. Int J Ophthalmol. 2010;3(3):257–260. doi:10.3980/j.issn.2222-3959.2010.03.18
   PubMed Web of Science ®Google Scholar
• Mittal V, Mittal R. Intracameral and topical voriconazole for fungal corneal endoexudates. Cornea. 2012;31(4):366–370. doi:10.1097/ICO.0b013e318233f0a8
   PubMed Web of Science ®Google Scholar
• Sharma B, Kataria P, Anand R, et al. Efficacy profile of intracameral amphotericin B. Often Forgotten Step Asia Pac J Ophthalmol. 2015;4(6):360–366. doi:10.1097/APO.0000000000000107
   PubMedGoogle Scholar
• Sharma N, Sankaran P, Agarwal T, et al. Evaluation of intracameral amphotericin B in the management of fungal keratitis: randomized controlled trial. Ocul Immunol Inflamm. 2016;24(5):493–497. doi:10.3109/09273948.2015.1057597
   PubMed Web of Science ®Google Scholar
• Maniam A, Min L, Phang L, Vendargon F, Othman O. Postoperative Fungal Keratitis managed by anterior chamber washout and intracameral amphotericin-B: a report of two cases. Cureus. 2021;13:12.
   Web of Science ®Google Scholar
• Dong LK, Krebs DB. An intracameral approach for recalcitrant fungal keratitis. Am J Ophthalmol Case Rep. 2022;25:101369. doi:10.1016/j.ajoc.2022.101369
   PubMedGoogle Scholar
• Nasrin Y, Satya HR, Rath R. A hospital-based observational comparative study of efficacy of intracameral voriconazole and oral ketoconazole in deep keratomycosis. Ophthalmol J. 2022;7(3):6–11. doi:10.5603/OJ.2021.0045
   Google Scholar
• Okonkwo A, Sethi K, Anand S. Repeated intracameral amphotericin B: a safe approach for management of fungal anterior chamber reactivations after therapeutic penetrating keratoplasty. Cornea. 2023;42(8):1041–1044. doi:10.1097/ICO.0000000000003268
   PubMed Web of Science ®Google Scholar
• Arboleda A, Miller D, Cabot F, et al. Assessment of rose bengal versus riboflavin photodynamic therapy for inhibition of fungal keratitis isolates. Am J Ophthalmol. 2014;158(1):64–70.e2. doi:10.1016/j.ajo.2014.04.007
   PubMed Web of Science ®Google Scholar
• Amescua G, Arboleda A, Nikpoor N, et al. Rose bengal photodynamic antimicrobial therapy: a novel treatment for resistant fusarium keratitis. Cornea. 2017;36(9):1141–1144. doi:10.1097/ICO.0000000000001265
   PubMed Web of Science ®Google Scholar
• Zhu H, Alt C, Webb RH, Melki S, Kochevar IE. Corneal crosslinking with rose bengal and green light: efficacy and safety evaluation. Cornea. 2016;35(9):1234–1241. doi:10.1097/ICO.0000000000000916
   PubMed Web of Science ®Google Scholar
• Spoerl E, Wollensak G, Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res. 2004;29(1):35–40. doi:10.1080/02713680490513182
   PubMed Web of Science ®Google Scholar
• Wollensak G, Spoerl E, Wilsch M, Seiler T. Endothelial cell damage after riboflavin-ultraviolet-A treatment in the rabbit. J Cataract Refract Surg. 2003;29(9):1786–1790. doi:10.1016/S0886-3350(03)00343-2
   PubMed Web of Science ®Google Scholar
• Wollensak G. Histological changes in human cornea after cross-linking with riboflavin and ultraviolet A. Acta Ophthalmol. 2010;88(2):e17–8. doi:10.1111/j.1755-3768.2008.01474.x
   PubMed Web of Science ®Google Scholar
• Wollensak G, Spörl E, Seiler T. Treatment of keratoconus by collagen cross linking. Ophthalmologe. 2003;100(1):44–49. doi:10.1007/s00347-002-0700-3
   PubMed Web of Science ®Google Scholar
• Wollensak G, Wilsch M, Spoerl E, Seiler T. Collagen fiber diameter in the rabbit cornea after collagen crosslinking by riboflavin/UVA. Cornea. 2004;23(5):503–507. doi:10.1097/01.ico.0000105827.85025.7f
   PubMed Web of Science ®Google Scholar
• Wernli J, Schumacher S, Spoerl E, Mrochen M. The efficacy of corneal cross-linking shows a sudden decrease with very high intensity UV light and short treatment time. Invest Ophthalmol Vis Sci. 2013;54(2):1176–1180. doi:10.1167/iovs.12-11409
   PubMed Web of Science ®Google Scholar
• Sinjab M, Cummings A. Corneal Collagen Cross Linking. London: Springer International Publishing; 2017.
   Google Scholar
• Iseli HP, Thiel MA, Hafezi F, Kampmeier J, Seiler T. Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea. 2008;27(5):590–594. doi:10.1097/ICO.0b013e318169d698
   PubMed Web of Science ®Google Scholar
• Hafezi F, Randleman JB. PACK-CXL: defining CXL for infectious keratitis. J Refract Surg. 2014;30(7):438–439. doi:10.3928/1081597X-20140609-01
   PubMed Web of Science ®Google Scholar
• Richoz O, Gatzioufas Z, Francois P, Schrenzel J, Hafezi F. Impact of fluorescein on the antimicrobial efficacy of photoactivated riboflavin in corneal collagen cross-linking. J Refract Surg. 2013;29(12):842–845. doi:10.3928/1081597X-20131115-01
   PubMed Web of Science ®Google Scholar
• Ting DSJ, Henein C, Said DG, Dua HS. Photoactivated chromophore for infectious keratitis - Corneal cross-linking (PACK-CXL): a systematic review and meta-analysis. Ocul Surf. 2019;17(4):624–634. doi:10.1016/j.jtos.2019.08.006
   PubMed Web of Science ®Google Scholar
• Anwar HM, El-Danasoury AM, Hashem AN. Corneal collagen crosslinking in the treatment of infectious keratitis. Clin Ophthalmol. 2011;5:1277–1280. doi:10.2147/OPTH.S24532
   PubMedGoogle Scholar
• Panda A, Krishna SN, Kumar S. Photo-activated riboflavin therapy of refractory corneal ulcers. Cornea. 2012;31(10):1210–1213. doi:10.1097/ICO.0b013e31823f8f48
   PubMed Web of Science ®Google Scholar
• Price MO, Tenkman LR, Schrier A, Fairchild KM, Trokel SL, Price FW. Photoactivated riboflavin treatment of infectious keratitis using collagen cross-linking technology. J Refract Surg. 2012;28(10):706–713. doi:10.3928/1081597X-20120921-06
   PubMed Web of Science ®Google Scholar
• Müller L, Thiel MA, Kipfer-Kauer AI, Kaufmann C. Corneal cross-linking as supplementary treatment option in melting keratitis: a case series. Klin Monbl Augenheilkd. 2012;229(4):411–415. doi:10.1055/s-0031-1299420
   PubMed Web of Science ®Google Scholar
• Li Z, Jhanji V, Tao X, Yu H, Chen W, Mu G. Riboflavin/ultraviolet light-mediated crosslinking for fungal keratitis. Br J Ophthalmol. 2013;97(5):669–671. doi:10.1136/bjophthalmol-2012-302518
   PubMed Web of Science ®Google Scholar
• Sorkhabi R, Sedgipoor M, Mahdavifard A. Collagen cross-linking for resistant corneal ulcer. Int Ophthalmol. 2013;33(1):61–66. doi:10.1007/s10792-012-9633-2
   PubMed Web of Science ®Google Scholar
• Tabibian D, Richoz O, Riat A, Schrenzel J, Hafezi F. Accelerated photoactivated chromophore for keratitis-corneal collagen cross-linking as a first-line and sole treatment in early fungal keratitis. J Refract Surg. 2014;30(12):855–857. doi:10.3928/1081597X-20141113-06
   PubMed Web of Science ®Google Scholar
• Said DG, Elalfy MS, Gatzioufas Z, et al. Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting. Ophthalmology. 2014;121(7):1377–1382. doi:10.1016/j.ophtha.2014.01.011
   PubMed Web of Science ®Google Scholar
• Shetty R, Nagaraja H, Jayadev C, Shivanna Y, Kugar T. Collagen crosslinking in the management of advanced non-resolving microbial keratitis. Br J Ophthalmol. 2014;98(8):1033–1035. doi:10.1136/bjophthalmol-2014-304944
   PubMed Web of Science ®Google Scholar
• Vajpayee RB, Shafi SN, Maharana PK, Sharma N, Jhanji V. Evaluation of corneal collagen cross-linking as an additional therapy in mycotic keratitis. Clin Exp Ophthalmol. 2015;43(2):103–107. doi:10.1111/ceo.12399
   PubMed Web of Science ®Google Scholar
• Uddaraju M, Mascarenhas J, Das MR, et al. Corneal cross-linking as an adjuvant therapy in the management of recalcitrant deep stromal fungal keratitis: a randomized trial. Am J Ophthalmol. 2015;160(1):131–4.e5. doi:10.1016/j.ajo.2015.03.024
   PubMed Web of Science ®Google Scholar
• Igal V, Pikkel Igal YS, Pikkel YY. Corneal cross-linking as a treatment for fungal keratitis associated with corneal melting. Case Rep Ophthalmol. 2017;8(1):148–151. doi:10.1159/000456537
   PubMedGoogle Scholar
• Erdem E, Harbiyeli II, Boral H, Ilkit M, Yagmur M, Ersoz R. Corneal collagen cross-linking for the management of mycotic keratitis. Mycopathologia. 2018;183(3):521–527. doi:10.1007/s11046-018-0247-8
   PubMed Web of Science ®Google Scholar
• Prajna NV, Radhakrishnan N, Lalitha P, et al. Cross-linking-assisted infection reduction: a randomized clinical trial evaluating the effect of adjuvant cross-linking on outcomes in fungal keratitis. Ophthalmology. 2020;127(2):159–166. doi:10.1016/j.ophtha.2019.08.029
   PubMed Web of Science ®Google Scholar
• Mikropoulos DG, Kymionis GD, Voulgari N, et al. Intraoperative photoactivated chromophore for infectious keratitis-corneal cross-linking (PACK-CXL) during penetrating keratoplasty for the management of fungal keratitis in an immunocompromised patient. Ophthalmol Ther. 2019;8(3):491–495. doi:10.1007/s40123-019-0196-4
   PubMed Web of Science ®Google Scholar
• Wei A, Wang K, Wang Y, Gong L, Xu J, Shao T. Evaluation of corneal cross-linking as adjuvant therapy for the management of fungal keratitis. Graefes Arch Clin Exp Ophthalmol. 2019;257(7):1443–1452. doi:10.1007/s00417-019-04314-1
   PubMed Web of Science ®Google Scholar
• Bamdad S, Khalili MR, Khosravi A, Attarzade A, Movahedan H, Nejabat M. Corneal cross-linking as an adjunct for the management of refractory fungal keratitis. Middle East Afr J Ophthalmol. 2020;27(4):204–209. doi:10.4103/meajo.MEAJO_130_19
   PubMed Web of Science ®Google Scholar
• González Castellanos JC, Osaba M, Reviglio V, Canchi MT, Arrigone MC, Reviglio VE. Early treatment of bilateral fungal keratitis with corneal cross-linking as adjuvant therapy. Oxford Med Case Rep. 2020;2020(6):omaa032. doi:10.1093/omcr/omaa032
   PubMed Web of Science ®Google Scholar
• Hafezi F, Munzinger A, Goldblum D, Hillen M, Tandogan T. Repeated high-fluence accelerated slitlamp-based photoactivated chromophore for keratitis corneal cross-linking for treatment-resistant fungal keratitis. Cornea. 2022;41(8):1058–1061. doi:10.1097/ICO.0000000000002973
   PubMed Web of Science ®Google Scholar
• Khurana S, Gupta P, Gupta A, Sharma S, Ram J. Accelerated photoactivated chromophore for infectious keratitis-collagen cross-linking in deep mycotic keratitis. Indian J Ophthalmol Case Rep. 2022;2(1):257. doi:10.4103/ijo.IJO_998_21
   Google Scholar
• Hafezi F, Hosny M, Shetty R, et al. PACK-CXL vs. antimicrobial therapy for bacterial, fungal, and mixed infectious keratitis: a prospective randomized phase 3 trial. Eye and Vision. 2022;9(1):2. doi:10.1186/s40662-021-00272-0
   Web of Science ®Google Scholar
• Awad R, Hafezi F, Ghaith AA, et al. Comparison between three different high fluence UVA levels in corneal collagen cross-linking for treatment of experimentally induced fungal keratitis in rabbits. Eur J Ophthalmol. 2022;32(4):1907–1914. doi:10.1177/11206721221092224
   PubMed Web of Science ®Google Scholar
• Elbassiouny R, Ghaith A, Farhad H, Baddour M, Eman S, Elmassry A. Evaluation of the efficacy of high-fluence corneal collagen cross-linking in fusarium corneal ulcer in rabbits. J Egypt Ophthalmol Soc. 2022;115(2):43–48. doi:10.4103/ejos.ejos_35_21
   Google Scholar